IL149618A0 - Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof - Google Patents

Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof

Info

Publication number: IL149618A0
Authority: IL; Israel
Prior art keywords: thiazolidinedione; preparation; pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1999-11-16

Application number

IL14961800A

Other languages

English (en)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2000-11-16

Publication date

2002-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL149618(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-16 Priority claimed from GBGB9927120.7A external-priority patent/GB9927120D0/en

1999-11-16 Priority claimed from GBGB9927119.9A external-priority patent/GB9927119D0/en

2000-05-31 Priority claimed from GB0013236A external-priority patent/GB0013236D0/en

2000-05-31 Priority claimed from GB0013240A external-priority patent/GB0013240D0/en

2000-11-16 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-12-01 Publication of IL149618A0 publication Critical patent/IL149618A0/xx

Links

ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
229940123464 Thiazolidinedione Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL14961800A 1999-11-16 2000-11-16 Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof IL149618A0 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9927120.7A GB9927120D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GBGB9927119.9A GB9927119D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GB0013236A GB0013236D0 (en)	2000-05-31	2000-05-31	Novel composition and use
GB0013240A GB0013240D0 (en)	2000-05-31	2000-05-31	Novel composition and use
PCT/GB2000/004368 WO2001035941A2 (fr)	1999-11-16	2000-11-16	Nouvelle composition et utilisation

Publications (1)

Publication Number	Publication Date
IL149618A0 true IL149618A0 (en)	2002-12-01

Family

ID=27447849

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL14961800A IL149618A0 (en)	1999-11-16	2000-11-16	Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof
IL149618A IL149618A (en)	1999-11-16	2002-05-13	Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof
IL190220A IL190220A0 (en)	1999-11-16	2008-03-17	Novel composition and use

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL149618A IL149618A (en)	1999-11-16	2002-05-13	Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof
IL190220A IL190220A0 (en)	1999-11-16	2008-03-17	Novel composition and use

Country Status (40)

Country	Link
US (1)	US8236345B2 (fr)
EP (3)	EP1913945A3 (fr)
JP (2)	JP4865975B2 (fr)
KR (1)	KR100760063B1 (fr)
CN (1)	CN1222290C (fr)
AP (1)	AP1389A (fr)
AR (2)	AR030920A1 (fr)
AT (1)	ATE292466T1 (fr)
AU (3)	AU775654B2 (fr)
BG (1)	BG65616B1 (fr)
BR (1)	BR0015605A (fr)
CA (1)	CA2388846A1 (fr)
CO (1)	CO5300392A1 (fr)
CZ (1)	CZ302500B6 (fr)
DE (1)	DE60019329T2 (fr)
DK (1)	DK1231918T3 (fr)
DZ (1)	DZ3251A1 (fr)
EA (1)	EA004878B1 (fr)
ES (1)	ES2240199T3 (fr)
HK (1)	HK1049788B (fr)
HR (1)	HRP20020416B1 (fr)
HU (1)	HU229960B1 (fr)
IL (3)	IL149618A0 (fr)
MA (1)	MA25567A1 (fr)
ME (1)	ME00318B (fr)
MX (1)	MXPA02005005A (fr)
MY (1)	MY125516A (fr)
NO (1)	NO329926B1 (fr)
NZ (1)	NZ518946A (fr)
OA (1)	OA12513A (fr)
PE (1)	PE20011011A1 (fr)
PL (1)	PL200943B1 (fr)
PT (1)	PT1231918E (fr)
RS (1)	RS51343B (fr)
SI (1)	SI1231918T1 (fr)
SK (1)	SK286985B6 (fr)
TW (1)	TWI240626B (fr)
UA (1)	UA73150C2 (fr)
UY (1)	UY26439A1 (fr)
WO (1)	WO2001035941A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2407713A1 (fr) *	2000-05-01	2001-11-08	Aeropharm Technology, Inc.	Formulation de noyaux
JP2004536842A (ja) *	2001-07-10	2004-12-09	エアロファームテクノロジーインコーポレイテッド	トログリタゾンおよびビグアナイドを含むコア製剤
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
WO2003105809A1 (fr) *	2002-06-17	2003-12-24	Themis Laboratories Private Limited	Comprimes multicouche contenant des thiazolidinediones et des biguanides et procedes de production desdits comprimes
WO2004006921A1 (fr) *	2002-07-11	2004-01-22	Takeda Pharmaceutical Company Limited	Procede de production d'une preparation recouverte
US8637512B2 (en) *	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
KR20120034211A (ko) *	2002-09-20	2012-04-10	안드렉스 랩스 엘엘씨	약제학적 정제
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) *	2002-10-07	2007-11-26		Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
US7976853B2 (en)	2003-01-29	2011-07-12	Takeda Pharmaceutical Company Limited	Process for producing coated preparation
FR2858556B1 (fr) *	2003-08-06	2006-03-10	Galenix Innovations	Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
JP4739189B2 (ja) *	2004-04-14	2011-08-03	武田薬品工業株式会社	固形製剤
JPWO2006011397A1 (ja) *	2004-07-27	2008-05-01	興和株式会社	糖尿病の予防または治療のための薬剤
CA2607419C (fr)	2005-04-26	2014-06-17	Dainippon Sumitomo Pharma Co., Ltd.	Preparation granulaire contenant un derive de biguanide
AU2006328328B2 (en) *	2005-12-22	2012-08-30	Takeda Pharmaceutical Company Limited	Solid preparation containing an insulin sensitizer
FR2896159B1 (fr)	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
WO2008078390A1 (fr)	2006-12-26	2008-07-03	Fujitsu Limited	Dispositif de compression et de restauration de données
MY147596A (en)	2007-02-01	2012-12-31	Takeda Pharmaceutical	Solid preparation comprising alogliptin and pioglitazone
JP5467870B2 (ja)	2007-02-09	2014-04-09	アルファファームピーティーワイリミテッド	異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
TR200803177A2 (tr) *	2008-05-06	2009-11-23	Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.	Antihiperglisemik etkili metformîn - pioglitazon formülasyonu.
US8846315B2 (en)	2008-08-12	2014-09-30	Zinfandel Pharmaceuticals, Inc.	Disease risk factors and methods of use
PE20110565A1 (es)	2008-08-12	2011-09-02	Zinfandel Pharmaceuticals Inc	Metodo de identificacion de factores de riesgo de la enfermedad
FR2951945B1 (fr) *	2009-11-05	2013-08-09	Sanofi Aventis	Composition pharmaceutique
ES2689107T3 (es) *	2009-11-13	2018-11-08	Astrazeneca Ab	Formulaciones de tabletas bicapa
EP2441442A1 (fr)	2010-10-08	2012-04-18	LEK Pharmaceuticals d.d.	Composition pharmaceutique comprenant un thiazolidinedione
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
PT2661266T (pt)	2011-01-07	2020-11-30	Anji Pharma Us Llc	Terapias com base em ligandos do recetor quimiossensorial
EA201391017A1 (ru)	2011-01-10	2014-04-30	Зинфандел Фармасьютикалз, Инк.	Способы и готовые лекарственные формы для лечения болезни альцгеймера
MX2014008190A (es)	2012-01-06	2015-02-04	Elcelyx Therapeutics Inc	Composiciones de biguanida y métodos para tratar transtornos metabólicos.
SG10201901922VA (en)	2012-01-06	2019-04-29	Elcelyx Therapeutics Inc	Compositions and methods for treating metabolic disorders
CN108451923B (zh) *	2018-05-31	2025-05-06	常州兰陵制药有限公司	盐酸二甲双胍速释胶囊及其制备方法
JP2023528565A (ja)	2020-04-01	2023-07-05	ハンジョウジョンメイフアドンファーマシューティカルシーオー．，エルティーディー．	Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法
EP4141008A4 (fr)	2020-04-01	2024-04-17	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	Sel d'acide pharmaceutiquement acceptable de base libre d'agoniste du récepteur glp-1, et son procédé de préparation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4613596Y1 (fr) *	1969-06-02	1971-05-14
DE2347531A1 (de) *	1973-09-21	1975-04-30	Hoechst Ag	Arzneizubereitungen zur oralen diabetes-behandlung
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
US4999226A (en)	1988-06-01	1991-03-12	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
JPH0553521A (ja)	1991-08-28	1993-03-05	Mitsubishi Electric Corp	オートトラツキング型ｃｒｔデイスプレイモニタ
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
IT1255522B (it)	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en)	1993-09-21	2001-02-06	Jagotec Ag	Pharmaceutical tablet capable of liberating one or more drugs at different release rates
TW438587B (en)	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
DE19539361A1 (de)	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
GB9612496D0 (en)	1996-06-14	1996-08-14	De La Rue Thomas & Co Ltd	Security device
TW522014B (en)	1997-02-07	2003-03-01	Sepracor Inc	Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US20020004515A1 (en)	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
EP1787646A3 (fr) *	1997-06-18	2007-10-03	Smithkline Beecham Plc	Nouveau procédé de traitement
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
EP1063973B1 (fr)	1998-03-19	2016-11-16	Bristol-Myers Squibb Company	Systeme d'apport a liberation lente biphasique destine a des medicaments a solubilite elevee et procede associe
US6099859A (en)	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
US20040102486A1 (en)	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
AR023700A1 (es)	1998-11-12	2002-09-04	Smithkline Beecham Plc	Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB9824893D0 (en)	1998-11-12	1999-01-06	Smithkline Beckman Corp	Novel method of treatment
US20040081697A1 (en)	1998-11-12	2004-04-29	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
CZ20011629A3 (cs)	1998-11-12	2001-12-12	Smithkline Beecham Plc	Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
AU1403501A (en)	1999-11-16	2001-05-30	Smithkline Beecham Plc	Novel composition and use
US6296874B1 (en)	2000-05-01	2001-10-02	Aeropharm Technology Incorporated	Core formulation comprising troglitazone and abiguanide
US6451342B2 (en)	2000-05-01	2002-09-17	Aeropharm Technology Incorporated	Core formulation comprised of troglitazone and a biguanide
US6461639B2 (en)	2000-05-01	2002-10-08	Aeropharm Technology, Inc.	Core formulation
US6780432B1 (en)	2000-05-01	2004-08-24	Aeropharm Technology, Inc.	Core formulation
US6403121B1 (en)	2000-05-01	2002-06-11	Aeropharm Technology Incorporated	Core formulation
US6524621B2 (en)	2000-05-01	2003-02-25	Aeropharm Technology Inc.	Core formulation
GB0318824D0 (en)	2003-08-11	2003-09-10	Glaxo Group Ltd	Novel composition

2000
- 2000-11-15 AR ARP000106019A patent/AR030920A1/es active IP Right Grant
- 2000-11-15 MY MYPI20005360A patent/MY125516A/en unknown
- 2000-11-16 EP EP07120386A patent/EP1913945A3/fr not_active Withdrawn
- 2000-11-16 IL IL14961800A patent/IL149618A0/xx unknown
- 2000-11-16 HU HU0204122A patent/HU229960B1/hu unknown
- 2000-11-16 EA EA200200571A patent/EA004878B1/ru not_active IP Right Cessation
- 2000-11-16 MX MXPA02005005A patent/MXPA02005005A/es active IP Right Grant
- 2000-11-16 HK HK03100745.5A patent/HK1049788B/en not_active IP Right Cessation
- 2000-11-16 DK DK00976156T patent/DK1231918T3/da active
- 2000-11-16 KR KR1020027006271A patent/KR100760063B1/ko not_active Expired - Lifetime
- 2000-11-16 OA OA1200200145A patent/OA12513A/en unknown
- 2000-11-16 CA CA002388846A patent/CA2388846A1/fr not_active Abandoned
- 2000-11-16 UY UY26439A patent/UY26439A1/es not_active IP Right Cessation
- 2000-11-16 SK SK679-2002A patent/SK286985B6/sk not_active IP Right Cessation
- 2000-11-16 RS YUP-388/02A patent/RS51343B/sr unknown
- 2000-11-16 EP EP00976156A patent/EP1231918B1/fr not_active Expired - Lifetime
- 2000-11-16 ES ES00976156T patent/ES2240199T3/es not_active Expired - Lifetime
- 2000-11-16 AP APAP/P/2002/002505A patent/AP1389A/en active
- 2000-11-16 CN CNB008178224A patent/CN1222290C/zh not_active Expired - Lifetime
- 2000-11-16 CZ CZ20021679A patent/CZ302500B6/cs not_active IP Right Cessation
- 2000-11-16 HR HR20020416A patent/HRP20020416B1/xx not_active IP Right Cessation
- 2000-11-16 JP JP2001537934A patent/JP4865975B2/ja not_active Expired - Lifetime
- 2000-11-16 WO PCT/GB2000/004368 patent/WO2001035941A2/fr not_active Ceased
- 2000-11-16 UA UA2002064826A patent/UA73150C2/uk unknown
- 2000-11-16 DZ DZ003251A patent/DZ3251A1/fr active
- 2000-11-16 EP EP04078538A patent/EP1520581A1/fr not_active Withdrawn
- 2000-11-16 BR BR0015605-1A patent/BR0015605A/pt not_active Application Discontinuation
- 2000-11-16 PL PL355331A patent/PL200943B1/pl unknown
- 2000-11-16 ME MEP-2008-340A patent/ME00318B/fr unknown
- 2000-11-16 PT PT00976156T patent/PT1231918E/pt unknown
- 2000-11-16 SI SI200030697T patent/SI1231918T1/xx unknown
- 2000-11-16 DE DE60019329T patent/DE60019329T2/de not_active Expired - Lifetime
- 2000-11-16 NZ NZ518946A patent/NZ518946A/en not_active IP Right Cessation
- 2000-11-16 AT AT00976156T patent/ATE292466T1/de active
- 2000-11-16 PE PE2000001226A patent/PE20011011A1/es not_active Application Discontinuation
- 2000-11-16 AU AU14040/01A patent/AU775654B2/en not_active Expired
- 2000-11-20 CO CO00088045A patent/CO5300392A1/es not_active Application Discontinuation
- 2000-12-04 TW TW089125730A patent/TWI240626B/zh not_active IP Right Cessation
2002
- 2002-05-13 IL IL149618A patent/IL149618A/en unknown
- 2002-05-15 NO NO20022334A patent/NO329926B1/no not_active IP Right Cessation
- 2002-05-15 MA MA26640A patent/MA25567A1/fr unknown
- 2002-05-29 BG BG106747A patent/BG65616B1/bg unknown
2004
- 2004-11-04 AU AU2004226955A patent/AU2004226955B2/en not_active Expired
2006
- 2006-12-05 AR ARP060105370A patent/AR057970A2/es active IP Right Grant
2007
- 2007-07-18 US US11/779,546 patent/US8236345B2/en not_active Expired - Fee Related
2008
- 2008-03-17 IL IL190220A patent/IL190220A0/en unknown
- 2008-08-18 AU AU2008207375A patent/AU2008207375A1/en not_active Abandoned
2011
- 2011-08-11 JP JP2011175883A patent/JP5282130B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AP2002002505A0 (en)	2002-06-30
HK1049788A1 (en)	2003-05-30
AU2004226955A1 (en)	2004-12-02
AU2004226955B2 (en)	2008-08-28
SI1231918T1 (en)	2005-08-31
NO20022334D0 (no)	2002-05-15
AU775654B2 (en)	2004-08-12
PT1231918E (pt)	2005-08-31
EP1520581A1 (fr)	2005-04-06
DZ3251A1 (fr)	2001-05-25
UA73150C2 (uk)	2005-06-15
SK286985B6 (sk)	2009-08-06
AU2008207375A1 (en)	2008-09-11
CN1414852A (zh)	2003-04-30
AR030920A1 (es)	2003-09-03
WO2001035941A3 (fr)	2002-05-23
MY125516A (en)	2006-08-30
JP5282130B2 (ja)	2013-09-04
CO5300392A1 (es)	2003-07-31
DE60019329T2 (de)	2006-03-09
CN1222290C (zh)	2005-10-12
US8236345B2 (en)	2012-08-07
HRP20020416B1 (hr)	2011-04-30
DE60019329D1 (de)	2005-05-12
AR057970A2 (es)	2007-12-26
OA12513A (en)	2006-05-29
PL200943B1 (pl)	2009-02-27
IL190220A0 (en)	2008-11-03
YU38802A (sh)	2005-03-15
BG106747A (en)	2003-01-31
HK1049788B (en)	2005-11-04
MA25567A1 (fr)	2002-10-01
NO20022334L (no)	2002-07-09
JP4865975B2 (ja)	2012-02-01
EP1913945A3 (fr)	2008-04-30
SK6792002A3 (en)	2002-09-10
RS51343B (sr)	2011-02-28
PL355331A1 (en)	2004-04-19
NO329926B1 (no)	2011-01-24
US20070275054A1 (en)	2007-11-29
MEP34008A (en)	2011-02-10
HUP0204122A3 (en)	2006-01-30
UY26439A1 (es)	2001-07-31
JP2011252007A (ja)	2011-12-15
BG65616B1 (bg)	2009-03-31
DK1231918T3 (da)	2005-08-01
ME00318B (fr)	2011-05-10
KR20030019300A (ko)	2003-03-06
CA2388846A1 (fr)	2001-05-25
JP2003514012A (ja)	2003-04-15
EP1231918A2 (fr)	2002-08-21
WO2001035941A2 (fr)	2001-05-25
HUP0204122A2 (hu)	2003-03-28
EA004878B1 (ru)	2004-08-26
ES2240199T3 (es)	2005-10-16
MXPA02005005A (es)	2003-10-14
AP1389A (en)	2005-04-14
EA200200571A1 (ru)	2002-12-26
PE20011011A1 (es)	2001-10-28
KR100760063B1 (ko)	2007-09-18
WO2001035941A8 (fr)	2002-08-29
EP1231918B1 (fr)	2005-04-06
IL149618A (en)	2008-07-08
TWI240626B (en)	2005-10-01
AU1404001A (en)	2001-05-30
NZ518946A (en)	2003-10-31
HU229960B1 (hu)	2015-03-30
ATE292466T1 (de)	2005-04-15
BR0015605A (pt)	2002-07-09
EP1913945A2 (fr)	2008-04-23
CZ302500B6 (cs)	2011-06-22
HRP20020416A2 (en)	2004-08-31

Publication	Publication Date	Title
HUP0301325A3 (en)	2004-03-01	Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0203316A3 (en)	2004-07-28	Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0300618A3 (en)	2003-12-29	Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0302499A3 (en)	2012-02-28	Pharmaceutical compositions of estrogen-cyclodextrin complexes and process for their preparation
HUP0301315A3 (en)	2007-10-29	Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203902A3 (en)	2003-07-28	Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0204245A3 (en)	2004-12-28	Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203378A3 (en)	2004-07-28	Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0102711A3 (en)	2002-09-30	Epothilone derivatives and pharmaceutical compositions containing them and process for preparation the same
HUP0105021A3 (en)	2003-02-28	Compositions having improved delivery of actives and process for their preparation
HUP0104762A3 (en)	2002-10-28	Pharmaceutical moxifloxacin compositions and process for their preparation
IL150346A (en)	2010-12-30	Benzazole derivatives, their preparation and pharmaceutical compositions containing them
HUP0202731A3 (en)	2003-10-28	O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0302130A3 (en)	2005-06-28	Combination pharmaceutical compositions and process for their preparation
HUP0201516A3 (en)	2003-03-28	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en)	2002-11-28	Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en)	2004-12-28	Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9803040A3 (en)	2001-04-28	Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0201402A3 (en)	2003-12-29	Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
AP2000002010A0 (en)	2000-12-31	Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
AP2000001829A0 (en)	2000-06-30	Substituted thiazolidinedione derivative process for its preparation and its pharmaceutical use
HUP0203184A3 (en)	2004-12-28	Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105481A3 (en)	2003-04-28	Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
HUP0202654A3 (en)	2003-11-28	Pharmaceutical compositions of fibrinolytic agent and process for preparation thereof
HUP0200929A3 (en)	2004-03-29	Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof